Serum Neurofilament Light Level May Predict MS Progression

High serum levels of neurofilament light are associated with an increased risk for disease progression at 2 years. Clinical, MRI, and OCT measures are not associated with this risk, however.

Related Keywords

Norway ,Oslo ,Canada ,Toronto ,Ontario ,Berlin ,Germany ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,E Ann Yeh ,Synne Brune ,Research In Multiple Sclerosis ,Neuroinflammatory Disorders Program ,Oslo University Hospital ,University Of Oslo ,European Committee For Treatment ,Medscape Medical ,European Committee ,Multiple Sclerosis ,Toward Clinical Practice ,Sick Children ,Relapsing Remitting Multiple Sclerosis ,Arms ,Ultiple Sclerosis Relapsing Remitting ,Primary Progressive Multiple Sclerosis ,Pms ,Multiple Sclerosis Imaging ,S Imaging ,Maging In Multiple Sclerosis ,Maging In Ms ,Maging Studies In Multiple Sclerosis ,Maging Studies In Ms ,Ms Lesion ,Ultiple Sclerosis Lesion ,Multiple Sclerosis Prognosis ,S Prognosis ,Ultiple Sclerosis Prognostic Factors , ,